
MidEuropa takes majority stake in Optegra
CEE-focused sponsor MidEuropa has taken a majority stake in UK-based ophthalmology group Optegra, while previous owner H2 Equity retains a minority stake.
The buyer said in a statement that Optegra was well-positioned for organic growth within its current footprint and to expand into new geographies.
MidEuropa held a first close on its latest fund, MidEuropa V, in December 2018, and an undisclosed final close in early January 2020.
MidEuropa joined Partners Group, HIG and CapVest in bidding for the asset with bids tabled up to EUR 330m in an earlier round, as reported.
The process, which marketed Optegra off EUR 25m EBITDA, had reportedly been put on ice after tabled bids did not reach expectations, according to Unquote's sister publication Mergermarket.
H2 mandated Lincoln to explore an exit earlier in the year, just three years after it acquired the company via the 2016 vintage H2 Equity Partners Fund V.
The sponsor is reinvesting in the asset alongside management with the three parties looking to build out the pan-European platform, said MidEuropa in a statement.
MidEuropa's other healthcare assets include CEE hospitals Regina Maria and MediGroup, which it merged and moved to a continuation fund in 2021, and Polish diagnostic laboratory group Diagnostyka.
The transaction is expected to complete in the first half of 2023.
Company
Optegra is a European ophthalmology platform operating in Poland, Czech Republic, Slovakia and the UK. It offers a wide range of procedures including cataract, age-related macular degeneration (AMD), and vision correction for both public and private patients through 29 facilities.
Advisors
MidEuropa – Moelis (M&A); White & Case (legal); LEK (commercial); PwC (financial, tax and IT); and Houlihan Lokey (financing advisory).
H2 Equity Partners – Lincoln International (M&A); Eversheds Sutherland (legal); Mansfield Advisors (commercial); PwC (financial); Grant Thornton (tax); and Diligize (IT).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater